https://www.scitechpresssouthdakota.com/article/906977352-suse-honors-global-innovators-with-2026-customer-awards-at-susecon-prague Sci-Tech Press South Dakota en PressRelease 2026-04-20T17:34:22+00:00 SUSE Honors Global Innovators with 2026 Customer Awards at SUSECON Prague https://ml.globenewswire.com/media/09765710-f488-4be3-90cb-63d10be39718/small/suse-logo-vert-l-green-pos-srgb-resized-jpg.jpg https://www.scitechpresssouthdakota.com/article/906977447-canto-partners-with-rutgers-university-to-advance-professional-education-in-digital-asset-management Sci-Tech Press South Dakota en PressRelease 2026-04-20T17:04:00+00:00 Canto Partners with Rutgers University to Advance Professional Education in Digital Asset Management https://ml.globenewswire.com/media/00651127-5f56-4633-bacf-5c09a7c170f5/small/canto-logo-png.png https://www.scitechpresssouthdakota.com/article/906972983-lirum-therapeutics-announces-positive-lx-101-data-selected-for-presentation-at-the-2026-american-association-for-cancer-research-aacr-annual-meeting Sci-Tech Press South Dakota en PressRelease 2026-04-20T17:00:00+00:00 Lirum Therapeutics Announces Positive LX-101 Data Selected for Presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting https://ml.globenewswire.com/media/09223099-97d9-4c04-8b22-ce639c0fd876/small/lirum-therapeutics-inc-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906972452-wearable-devices-announces-a-warrant-inducement-transaction-for-5-0-million-in-gross-proceeds Sci-Tech Press South Dakota en PressRelease 2026-04-20T16:46:39+00:00 Wearable Devices Announces a Warrant Inducement Transaction for $5.0 Million in Gross Proceeds https://ml.globenewswire.com/media/2fc8eace-a0eb-49ae-ae65-a1817cffada0/small/wearablelogo1-jpg.jpg https://www.scitechpresssouthdakota.com/article/906972365-agilis-announces-global-growth-of-safety-focused-social-matching-platform Sci-Tech Press South Dakota en PressRelease 2026-04-20T16:46:00+00:00 Agilis Announces Global Growth of Safety-Focused Social Matching Platform https://ml.globenewswire.com/media/a1a08069-b3cd-4a66-8af5-238346802382/small/agilis-dating-logo.png https://www.scitechpresssouthdakota.com/article/906972345-cyber-a-i-group-appoints-irving-bruckstein-as-chief-executive-officer Sci-Tech Press South Dakota en PressRelease 2026-04-20T16:32:00+00:00 Cyber A.I. Group Appoints Irving Bruckstein as Chief Executive Officer https://ml.globenewswire.com/media/f331e89a-451d-456c-b3ef-7cb04fb38ee0/medium/cyber-a-i-group-appoints-irving-bruckstein-as-chief-executiv.png https://www.scitechpresssouthdakota.com/article/906967650-genfit-publication-of-the-2026-extra-financial-report-fiscal-year-2025 Sci-Tech Press South Dakota en PressRelease 2026-04-20T16:00:00+00:00 GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1lbg==/tiny/GENFIT-S-A-.png https://www.scitechpresssouthdakota.com/article/906967654-genfit-publication-du-rapport-de-performance-extra-financi-re-2026-exercice-2025 Sci-Tech Press South Dakota en PressRelease 2026-04-20T16:00:00+00:00 GENFIT : Publication du rapport de performance extra-financière 2026 (exercice 2025) https://ml-eu.globenewswire.com/media/NWQ4ZDk0NzEtNGJjYy00N2I0LTljZTgtNTVlNGMzMWE3NmIyLTEwMTEyNjgtMjAyNi0wNC0yMC1mcg==/tiny/GENFIT-S-A-.png https://www.scitechpresssouthdakota.com/article/906967639-briefcast-publishes-transcript-entera-bio-s-osteoporosis-kol-roundtable-on-eb613-oral-anabolic-tablet-opportunity Sci-Tech Press South Dakota en PressRelease 2026-04-20T15:59:00+00:00 BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613 - Oral Anabolic Tablet Opportunity https://ml-eu.globenewswire.com/Resource/Download/79a80d3e-996b-473e-93b6-d034972ac6a3/screenshot-2026-04-20-at-15-12-20.png https://www.scitechpresssouthdakota.com/article/906963293-sunvega-advances-vertical-ai-for-the-home-sector-delivering-controllable-production-ready-solutions-through-integrated-ai-and-3d-workflows Sci-Tech Press South Dakota en PressRelease 2026-04-20T15:41:57+00:00 Sunvega Advances Vertical AI for the Home Sector: Delivering Controllable, Production-Ready Solutions Through Integrated AI and 3D Workflows https://ml.globenewswire.com/media/906064ed-7510-4ceb-9924-b5e91a37a316/medium/sunvega-ai-powered-design-workflow.jpg https://www.scitechpresssouthdakota.com/article/906959127-aptean-introduces-ai-platform-and-ai-agents-for-business-central-on-premises-customers Sci-Tech Press South Dakota en PressRelease 2026-04-20T15:04:33+00:00 Aptean introduces AI platform and AI agents for Business Central On-Premises Customers  https://ml.globenewswire.com/media/2246c26d-451a-4606-8d5c-ae8e19f259f0/small/aptean-logo-black-150ppi-jpg.jpg https://www.scitechpresssouthdakota.com/article/906959136-aptean-presenta-la-plataforma-de-ia-y-agentes-de-ia-para-clientes-on-premises-de-business-central Sci-Tech Press South Dakota en PressRelease 2026-04-20T15:04:33+00:00 Aptean presenta la plataforma de IA y agentes de IA para clientes on-premises de Business Central https://ml.globenewswire.com/media/2246c26d-451a-4606-8d5c-ae8e19f259f0/small/aptean-logo-black-150ppi-jpg.jpg https://www.scitechpresssouthdakota.com/article/906959284-aptean-apresenta-plataforma-de-ia-e-agentes-de-ia-para-clientes-do-business-central-on-premises Sci-Tech Press South Dakota en PressRelease 2026-04-20T15:04:33+00:00 Aptean apresenta plataforma de IA e agentes de IA para clientes do Business Central On-Premises https://ml.globenewswire.com/media/2246c26d-451a-4606-8d5c-ae8e19f259f0/small/ https://www.scitechpresssouthdakota.com/article/906959057-arctic-wolf-introduces-decipio-a-community-tool-to-catch-credential-theft-with-defense-first-ai Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:46:08+00:00 Arctic Wolf Introduces Decipio, a Community Tool to Catch Credential Theft with Defense‑First AI https://ml.globenewswire.com/media/62df1097-f4bf-4e0a-af8a-9ce79bf1257b/small/arctic-wolf-company-logo.png https://www.scitechpresssouthdakota.com/article/906954693-lis-technologies-inc-announces-opening-keynote-presentation-and-platinum-sponsorship-of-reuters-events-smr-and-advanced-reactor-2026-conference Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:15:00+00:00 LIS Technologies Inc. Announces Opening Keynote Presentation and Platinum Sponsorship of Reuters Events’ SMR and Advanced Reactor 2026 Conference https://ml.globenewswire.com/media/1c62f64f-e754-43b1-9508-e1648ab1b855/medium/lis-technologies-inc.png https://www.scitechpresssouthdakota.com/article/906954710-alayacare-and-eitan-medical-partner-to-eliminate-manual-transcription-for-home-infusion-nurses Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:14:14+00:00 AlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nurses https://ml.globenewswire.com/media/80920392-a416-454f-9f6c-c63983a6924e/medium/alayacare-and-eitan-medical-partner-to-eliminate-manual-tran.png https://www.scitechpresssouthdakota.com/article/906954447-26-mlss-drive-restb-ai-past-1-million-real-estate-agents-with-nationwide-ai-deployment Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:00:00+00:00 26 MLSs drive Restb.ai past 1 million real estate agents with nationwide AI deployment https://ml.globenewswire.com/media/d97056ab-369f-4174-aef5-043bf5bb2c2b/medium/dominik-pogorzelski-restb-ai.jpeg https://www.scitechpresssouthdakota.com/article/906954507-kaltura-brings-conversational-avatars-and-video-intelligence-to-the-world-s-most-popular-content-management-systems-with-native-integrations-for Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:00:00+00:00 Kaltura Brings Conversational Avatars and Video Intelligence to the World’s Most Popular Content Management Systems, With Native Integrations for Adobe Experience Manager, WordPress, and Drupal https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png https://www.scitechpresssouthdakota.com/article/906954521-renaissance-philanthropy-launches-forecasting-hub-to-predict-ai-s-impact-on-the-workforce Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:00:00+00:00 Renaissance Philanthropy Launches Forecasting Hub To Predict AI’s Impact On The Workforce https://ml.globenewswire.com/media/9efe6071-2ff8-4689-944b-f3c42cb503c5/small/renaissance-philanthropy-full-charcoal-rgb-1-png.png https://www.scitechpresssouthdakota.com/article/906954575-award-winning-human-capital-management-hcm-software-hibob-recognized-with-h3-hr-advisors-2026-hcm-technology-signal-award-for-workforce-change Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:00:00+00:00 Award-winning Human Capital Management (HCM) Software HiBob Recognized with H3 HR Advisors 2026 HCM Technology Signal Award for Workforce Change https://ml.globenewswire.com/media/0f860806-cf27-4f28-8416-4c6c8e38e3f4/small/screenshot-2025-09-24-at-1-25-41-pm-png.png https://www.scitechpresssouthdakota.com/article/906954630-bvi-announces-ce-mark-under-eu-mdr-for-virtuoso-a-brand-new-dual-function-surgical-platform Sci-Tech Press South Dakota en PressRelease 2026-04-20T14:00:00+00:00 BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.scitechpresssouthdakota.com/article/906954618-tilray-brands-marks-4-20-reaffirming-its-leadership-in-cannabis-and-commitment-to-advancing-medical-care Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:56:27+00:00 Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.scitechpresssouthdakota.com/article/906950148-hinweis-zum-nichtbeachten-bvi-medical-inc Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:46:44+00:00 HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.scitechpresssouthdakota.com/article/906950152-avis-ignorer-bvi-medical-inc Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:46:44+00:00 AVIS À IGNORER -- BVI Medical, Inc. https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.scitechpresssouthdakota.com/article/906946311-anaptys-completes-separation-of-first-tracks-biotherapeutics-and-now-exclusively-manages-gsk-and-vanda-financial-collaborations Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:15:00+00:00 Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.scitechpresssouthdakota.com/article/906946313-first-tracks-biotherapeutics-debuts-on-nasdaq-to-advance-therapies-for-autoimmune-diseases Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:15:00+00:00 First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.scitechpresssouthdakota.com/article/906946476-intelligent-bio-solutions-initiates-validation-study-for-rapid-drug-screening-cartridge-targeting-70-faster-results Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:15:00+00:00 Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.scitechpresssouthdakota.com/article/906945549-orion-pharma-s-odm-212-granted-orphan-drug-designation-in-mesothelioma-by-the-us-fda Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.scitechpresssouthdakota.com/article/906945558-coral-raises-12-5m-to-automate-healthcare-s-back-office-by-working-with-not-against-the-fax-machine Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Coral raises $12.5M to automate healthcare’s back office by working with, not against, the fax machine https://ml-eu.globenewswire.com/media/47abd368-8054-40f6-a3ab-c1f4c48262a1/small/black-png.png https://www.scitechpresssouthdakota.com/article/906945573-orion-pharman-odm-212-molekyyli-on-saanut-fda-n-harvinaisl-kestatuksen-orphan-drug-designation-mesoteliooman-hoidossa Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Orion Pharman ODM-212-molekyyli on saanut FDA:n harvinaislääkestatuksen (Orphan Drug Designation) mesoteliooman hoidossa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.scitechpresssouthdakota.com/article/906945590-inspired-entertainment-expands-global-igaming-presence-with-launch-in-south-africa Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Inspired Entertainment Expands Global iGaming Presence with Launch in South Africa https://ml.globenewswire.com/media/7656e726-a6a7-40f3-8499-154cbca52ba8/small/inspired-master-logo-on-blk-horizontal-cmyk-01-002-jpg.jpg https://www.scitechpresssouthdakota.com/article/906945593-redis-introduces-redis-feature-form-an-enterprise-feature-store-for-production-machine-learning Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Redis Introduces Redis Feature Form, an Enterprise Feature Store for Production Machine Learning https://ml.globenewswire.com/media/f5f9c647-e687-44f5-a11e-d440c619194a/small/redis-logo-red-rgb-png.png https://www.scitechpresssouthdakota.com/article/906945990-payscale-intelligence-cloud-sets-new-standard-in-compensation-intelligence Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Payscale Intelligence Cloud Sets New Standard in Compensation Intelligence https://ml.globenewswire.com/media/8d98e996-808c-4de5-8b7e-15bec433c6f4/small/payscale-full-logo-dark-png.png https://www.scitechpresssouthdakota.com/article/906945991-rpharmy-completes-soc-2-type-ii-audit-reinforcing-its-commitment-to-data-security-in-healthcare Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Rpharmy Completes SOC 2® Type II Audit, Reinforcing Its Commitment to Data Security in Healthcare https://ml.globenewswire.com/media/d4e2107a-158e-47f0-83ff-c3ff9cca678d/small/rpharmy-charcoal-logo-png.png https://www.scitechpresssouthdakota.com/article/906946039-darwin-ai-and-carahsoft-partner-to-deliver-ai-governance-and-visibility-platform-to-state-and-local-government-agencies Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Darwin AI and Carahsoft Partner to Deliver AI Governance and Visibility Platform to State and Local Government Agencies https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png https://www.scitechpresssouthdakota.com/article/906946063-tiger-data-launches-timescaledb-enterprise-a-self-managed-time-series-database-built-for-on-premises-and-edge-deployment Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Tiger Data Launches TimescaleDB Enterprise, a Self-Managed Time-Series Database Built for On-Premises and Edge Deployment https://ml.globenewswire.com/media/91dedd1a-a753-4e96-8961-fa3ee4aa9c66/small/tiger-data-logo.png https://www.scitechpresssouthdakota.com/article/906946066-silvaco-partners-with-itri-to-support-mcu-development-and-startup-innovation Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Silvaco Partners with ITRI to Support MCU Development and Startup Innovation https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906946091-immuneering-presents-genetic-data-at-aacr-annual-meeting-demonstrating-mechanism-to-improve-durability-and-survival-supporting-use-of-atebimetinib-in Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.scitechpresssouthdakota.com/article/906946144-inductive-automation-and-tiger-data-collaborate-to-modernize-the-industrial-historian-market Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Inductive Automation and Tiger Data Collaborate to Modernize the Industrial Historian Market https://ml.globenewswire.com/media/91dedd1a-a753-4e96-8961-fa3ee4aa9c66/small/tiger-data-logo.png https://www.scitechpresssouthdakota.com/article/906946305-scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026 https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906946315-canada-steps-up-as-a-global-manufacturing-partner-at-hannover-messe-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Canada Steps Up as a Global Manufacturing Partner at Hannover Messe 2026 https://ml.globenewswire.com/media/3a041e38-c23c-4a28-91f7-95b5a0bbc35a/small/ngen-colour-png.png https://www.scitechpresssouthdakota.com/article/906946318-le-canada-s-impose-comme-partenaire-mondial-de-premier-plan-en-fabrication-hannover-messe-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Le Canada s’impose comme partenaire mondial de premier plan en fabrication à Hannover Messe 2026 https://ml.globenewswire.com/media/1bf2940c-316a-479e-86fa-c2876b96617f/small/ngen-icon-512-png.png https://www.scitechpresssouthdakota.com/article/906946329-tripledart-releases-2026-state-of-saas-ppc-benchmark-report-based-on-60m-in-managed-ad-spend Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 TripleDart Releases 2026 State of SaaS PPC Benchmark Report Based on $60M+ in Managed Ad Spend https://ml.globenewswire.com/media/012b4e12-879e-43d0-a3b1-ac57aa344a2e/medium/template-preview.png https://www.scitechpresssouthdakota.com/article/906946361-velocity-logic-group-and-paytronix-partner-to-extend-loyalty-engagement-to-every-pump-transaction Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Velocity Logic Group and Paytronix Partner to Extend Loyalty Engagement to Every Pump Transaction https://ml.globenewswire.com/media/a0a47d40-4419-436d-b187-246e25669b64/small/access-paytronix-dark-002-1-png.png https://www.scitechpresssouthdakota.com/article/906946541-wearable-devices-announces-collaboration-with-meta-bounds-to-enable-intuitive-neural-control-for-ar-glasses Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Wearable Devices Announces Collaboration with Meta-Bounds to Enable Intuitive Neural Control for AR Glasses https://ml.globenewswire.com/media/2fc8eace-a0eb-49ae-ae65-a1817cffada0/small/wearablelogo1-jpg.jpg https://www.scitechpresssouthdakota.com/article/906946565-oragenics-reports-8-study-drug-doses-in-phase-iia-clinical-trial-of-onp-002-for-mild-traumatic-brain-injury Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906946797-avicanna-announces-agenda-for-6th-annual-clinical-symposium-on-cannabinoid-therapeutics Sci-Tech Press South Dakota en PressRelease 2026-04-20T13:00:00+00:00 Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics https://ml.globenewswire.com/media/dff23be4-6d2a-4fbc-a561-e13c2438d17a/medium/avicanna-announces-agenda-for-6th-annual-clinical-symposium.png https://www.scitechpresssouthdakota.com/article/906946607-alphaton-capital-relaunches-as-alpha-compute-corp-to-reflect-its-growing-ai-compute-business Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:53:05+00:00 AlphaTON Capital Relaunches as Alpha Compute Corp. to Reflect Its Growing AI Compute Business https://ml.globenewswire.com/media/dee2260b-6868-44db-b9bf-6ee9cf7c1a38/small/screenshot-2026-04-19-173237-png.png https://www.scitechpresssouthdakota.com/article/906941093-akari-therapeutics-reports-positive-preclinical-data-for-aktx-101-demonstrating-differentiated-cytotoxicity-for-first-in-class-trop2-adc-payload Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:35:00+00:00 Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.scitechpresssouthdakota.com/article/906940983-allogene-therapeutics-showcases-momentum-with-clinical-and-platform-advancements-in-allogeneic-car-t-at-aacr-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026 https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.scitechpresssouthdakota.com/article/906941042-cytodyn-presents-new-leronlimab-data-in-metastatic-triple-negative-breast-cancer-at-aacr-annual-meeting-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.scitechpresssouthdakota.com/article/906941181-new-generation-consumer-group-highlights-ai-infrastructure-expansion-and-growth-strategy-in-ceo-interview Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 New Generation Consumer Group Highlights AI Infrastructure Expansion and Growth Strategy in CEO Interview https://ml.globenewswire.com/media/NzAyNTFkNDItZjhlNy00ODJhLTllZDItMjEwN2M0NzI0NTUwLTUwMDE2MTM2Mi0yMDI2LTA0LTIwLWVu/tiny/New-Generation-Consumer-Group-.png https://www.scitechpresssouthdakota.com/article/906941197-from-ukraine-to-the-middle-east-gps-disruption-drives-demand-for-next-generation-defense-technology Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 From Ukraine to the Middle East, GPS Disruption Drives Demand for Next-Generation Defense Technology https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png https://www.scitechpresssouthdakota.com/article/906941213-when-science-becomes-an-asset-how-advancing-drug-pipelines-are-driving-real-time-valuation-in-biotech Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.scitechpresssouthdakota.com/article/906941231-jet-ai-and-flyexclusive-clear-path-to-closing-merger-in-second-quarter-of-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 Jet.AI and flyExclusive Clear Path to Closing Merger in Second Quarter of 2026 https://ml.globenewswire.com/media/b81682ef-e4f9-4164-81f6-6ea3e3d45bb3/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906941279-saic-awarded-new-75-2m-prism-task-order-to-advance-the-naval-air-systems-command-s-mission-critical-aviation-systems Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:30:00+00:00 SAIC Awarded New $75.2M PRISM Task Order to Advance the Naval Air Systems Command’s Mission-Critical Aviation Systems https://ml.globenewswire.com/media/016c4aa8-2126-4c0d-8d93-9c9291750523/small/saic-logo-rgb-navyblue-lg-jpg.jpg https://www.scitechpresssouthdakota.com/article/906940971-rachio-offers-20-off-smart-sprinkler-controllers-nationwide-april-19-26 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:24:00+00:00 Rachio Offers 20% Off Smart Sprinkler Controllers Nationwide April 19–26 https://ml.globenewswire.com/media/NDg0YTEwMjUtZTIwYS00M2JkLWI0M2EtYThjODBjMjA0N2M5LTEyNjg1MzgtMjAyNi0wNC0yMC1lbg==/tiny/Rachio.png https://www.scitechpresssouthdakota.com/article/906941032-pharmala-biotech-positioned-to-supply-u-s-expanded-access-pathway-for-mdma-established-by-presidential-executive-order Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:15:00+00:00 PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.scitechpresssouthdakota.com/article/906941539-helus-pharma-expresses-support-for-executive-order-advancing-psychedelic-research-and-regulatory-pathways-for-serious-mental-health-conditions Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:15:00+00:00 Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.scitechpresssouthdakota.com/article/906941461-foresight-enters-non-binding-term-sheet-for-17-5-million-strategic-investment-at-significant-premium-to-current-market-price-and-focus-on-defense Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:08:00+00:00 Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration https://ml.globenewswire.com/media/22d51a3f-a279-4de4-8d9c-1bc778fb7c19/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906937189-dlocal-limited-announces-dismissal-of-new-york-state-securities-class-action Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:05:00+00:00 dLocal Limited Announces Dismissal of New York State Securities Class Action https://ml.globenewswire.com/media/9d89c4dd-a073-4d8d-bf2a-f9ed62a34352/small/isologotipo-d-local-cmyk-1-jpg.jpg https://www.scitechpresssouthdakota.com/article/906936633-boehringer-ingelheim-expands-investment-in-computational-innovation-with-new-ai-accelerator-in-uk-s-knowledge-quarter Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter https://ml-eu.globenewswire.com/media/23506caa-2f73-498b-b15b-df82c00b9b21/medium/lord-patrick-vallance-and-steve-bates-obe-with-boehringer-re.jpg https://www.scitechpresssouthdakota.com/article/906936706-amneal-announces-additional-positive-interim-phase-4-elevate-pd-results-with-crexont-for-parkinson-s-disease-including-over-3-more-hours-of-daily Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.scitechpresssouthdakota.com/article/906936761-fulcrum-therapeutics-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-april-27-2026-at-8-00-a-m-et Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.scitechpresssouthdakota.com/article/906936917-carecloud-to-announce-first-quarter-2026-results-on-may-7-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 CareCloud to Announce First Quarter 2026 Results on May 7, 2026 https://ml.globenewswire.com/media/9d778df6-85d6-44e6-a170-2d364bbd93fd/small/carecloud-logo-blue-jpg.jpg https://www.scitechpresssouthdakota.com/article/906936942-mountain-warehouse-launches-composable-ecommerce-store-with-bigcommerce-to-accelerate-innovation-and-global-growth Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth https://ml.globenewswire.com/media/a953dd36-af2e-4b21-a5e8-45f93eb35143/small/commerce-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906936994-ascendis-pharma-announces-commencement-of-trading-of-its-ordinary-shares-on-nasdaq Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.scitechpresssouthdakota.com/article/906937040-cosciens-biopharma-inc-provides-update-on-its-plan-to-suspend-u-s-public-company-reporting-obligations Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png https://www.scitechpresssouthdakota.com/article/906937054-beyond-cancer-reports-updated-survival-and-safety-data-from-phase-1-uno-trial-presented-at-aacr-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 https://ml.globenewswire.com/media/c7ae3957-2763-4e5c-9594-57e1ba60ed59/small/beyond-air-the-magic-of-breathing-png.png https://www.scitechpresssouthdakota.com/article/906937067-cycurion-ceo-kevin-kelly-discusses-operational-execution-multi-year-contract-momentum-and-2026-growth-priorities-in-recent-interview Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview https://ml.globenewswire.com/media/6ece4f04-1a1d-49d2-80db-e2cc9294a173/small/cycu-png.png https://www.scitechpresssouthdakota.com/article/906937079-atsena-therapeutics-receives-data-monitoring-committee-recommendation-to-proceed-with-pivotal-part-c-cohort-of-phase-1-2-3-lighthouse-trial-evaluating Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937089-kyverna-presents-longer-term-phase-2-data-for-miv-cel-in-generalized-myasthenia-gravis-at-aan-demonstrating-deep-durable-responses-through-52-weeks Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.scitechpresssouthdakota.com/article/906937114-tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv108-an-allosteric-sarm1-inhibitor Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor https://ml.globenewswire.com/media/311d9377-979c-4384-9258-5b496e854edb/small/tenvie-logo-gradient-rgb-png.png https://www.scitechpresssouthdakota.com/article/906937116-bvi-gibt-bekannt-dass-virtuoso-eine-neue-chirurgische-plattform-mit-doppelfunktion-die-ce-kennzeichnung-gem-eu-mdr-erhalten-hat Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.scitechpresssouthdakota.com/article/906937119-bvi-annonce-l-obtention-du-marquage-ce-au-titre-du-r-glement-europ-en-sur-les-dispositifs-m-dicaux-pour-virtuoso-une-toute-nouvelle-plateforme Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction https://ml.globenewswire.com/media/0e7f0025-cd6d-4b42-9d31-9d16f1b74c40/small/bvi-logo-png.png https://www.scitechpresssouthdakota.com/article/906937121-calidi-biotherapeutics-presents-new-data-on-its-differentiated-approach-to-in-situ-t-cell-engagers-including-a-new-candidate-targeting-trop-2-at-the Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937126-biocardia-and-japan-pmda-align-on-acceptability-of-cardiamp-clinical-data-to-support-regulatory-approval-in-ischemic-heart-failure Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937127-aptean-introduces-ai-platform-and-ai-agents-for-business-central-on-premises-customers Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Aptean introduces AI platform and AI agents for Business Central On-Premises Customers https://ml.globenewswire.com/media/2246c26d-451a-4606-8d5c-ae8e19f259f0/small/aptean-logo-black-150ppi-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937129-ardelyx-appoints-biopharmaceutical-veteran-felecia-w-ettenberg-as-chief-legal-officer Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937134-phathom-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-thursday-april-30-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937172-axe-compute-unveils-compute-reserve-dashboard-giving-investors-a-unified-view-of-its-nasdaq-stock-and-operational-strategic-compute-reserve Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.scitechpresssouthdakota.com/article/906937184-askbio-s-viralgen-to-supply-commercial-scale-drug-product-for-regenerate-pd-investigational-gene-therapy-phase-ii-trial-for-parkinson-s-disease Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease https://ml.globenewswire.com/media/MTk3Y2I1OTYtYWYwYy00MDFmLWFlNTctYTVhZjUyODU0NTNlLTEyODY3MTItMjAyNi0wNC0yMC1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://www.scitechpresssouthdakota.com/article/906937332-genius-group-receives-icc-arbitration-award-wins-return-of-7-4-million-shares-and-8-0-million-cash-payment Sci-Tech Press South Dakota en PressRelease 2026-04-20T12:00:00+00:00 Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment https://ml.globenewswire.com/media/bc7e140d-8c14-43fd-a90e-3337d03946c3/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906937214-artelo-announces-peer-reviewed-publication-supporting-its-fabp5-inhibitor-art26-12-as-a-novel-pain-treatment-with-a-potentially-first-in-class-profile Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:50:00+00:00 Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937376-redcloud-to-enter-live-deployment-phase-as-combined-turkey-and-saudi-joint-ventures-represent-up-to-80-million-revenue Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:50:00+00:00 RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue https://ml.globenewswire.com/media/5c1cfb28-9945-43bb-a5bc-7789676cae2f/small/2023-redcloud-product-logos-13-e1691517467929-png.png https://www.scitechpresssouthdakota.com/article/906937263-psyence-biomed-positioned-as-world-s-only-licensed-pharmaceutical-grade-ibogaine-supplier-at-source Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:42:20+00:00 Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source https://ml.globenewswire.com/media/256a2527-4c30-46a1-a4d4-f37c89cfbff2/small/psyence-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937311-newcelx-updates-corporate-presentation-to-highlight-type-1-diabetes-flagship-program-following-strategic-collaboration-with-eledon-pharmaceuticals Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:37:00+00:00 NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937320-sleek-debuts-universal-profiles-at-sophie-passmann-book-club-pioneering-a-new-template-for-cultural-fan-activation Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:34:57+00:00 SLEEK Debuts Universal Profiles at Sophie Passmann Book Club, Pioneering a New Template for Cultural Fan Activation https://ml.globenewswire.com/media/73f83864-c4f1-4ecc-8e7f-a2f78113a874/small/lukso-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906937181-nexera-keepzone-ai-enters-into-white-label-agreement-to-develop-its-ai-based-voice-communication-decision-support-system Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:32:00+00:00 Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System https://ml.globenewswire.com/media/ab7d2c66-2303-4d0b-a5bb-53ef3a94593c/small/picture1-png.png https://www.scitechpresssouthdakota.com/article/906931891-cronos-group-inc-to-hold-2026-first-quarter-earnings-conference-call-on-may-11-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:30:00+00:00 Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026 https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932115-xtract-one-selected-by-health-pei-for-phased-rollout-of-tech-driven-security-systems-across-prince-edward-island Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:30:00+00:00 Xtract One Selected by Health PEI for Phased Rollout of Tech-Driven Security Systems Across Prince Edward Island https://ml.globenewswire.com/media/bf7fb1ad-3338-4238-9d5f-7145509090ab/small/xtractone-png.png https://www.scitechpresssouthdakota.com/article/906932304-briacell-presents-positive-phase-3-quality-of-life-and-phase-2-biomarker-data-at-the-2026-aacr-meeting Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:30:00+00:00 BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting https://ml.globenewswire.com/media/6fd3be2a-b6a2-4f35-a39c-dfd88259d9d0/small/briacell-logo-square-a-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932351-biogen-enters-into-agreement-with-tj-biopharma-for-felzartamab-assets-in-the-greater-china-region Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:30:00+00:00 Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932389-alphaton-capital-rebrands-as-alpha-compute-corp-to-reflect-its-growing-ai-compute-business Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:30:00+00:00 AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business https://ml.globenewswire.com/media/dee2260b-6868-44db-b9bf-6ee9cf7c1a38/small/screenshot-2026-04-19-173237-png.png https://www.scitechpresssouthdakota.com/article/906932568-clearmind-medicine-announced-positive-top-line-safety-results-cmnd-100-proprietary-psychedelic-treatment-meets-primary-endpoint-in-aud-trial Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:15:00+00:00 Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932305-kraig-biocraft-laboratories-advances-record-production-and-begins-processing-1-8-metric-tons-of-recombinant-spider-silk-cocoons Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:05:00+00:00 Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons https://ml.globenewswire.com/media/94451402-ffdd-4e78-b266-aeb3e0d7bb22/medium/jon-rice-kblbs-coo-pictured-with-less-than-4-of-the-companys.jpg https://www.scitechpresssouthdakota.com/article/906932225-invivyd-announces-chairman-marc-elia-to-speak-at-politico-health-care-summit Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:01:00+00:00 Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.scitechpresssouthdakota.com/article/906931864-radiopharm-theranostics-presents-initial-findings-from-phase-1-first-in-human-heat-clinical-trial-for-177lu-rad202-in-her2-solid-tumors-at-american Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png https://www.scitechpresssouthdakota.com/article/906931872-sagimet-biosciences-announces-appointment-of-andreas-grauer-md-as-chief-medical-officer Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.scitechpresssouthdakota.com/article/906931981-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.scitechpresssouthdakota.com/article/906932066-passage-bio-reports-updated-interim-data-from-uplift-d-trial-and-provides-regulatory-and-corporate-updates Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates https://ml.globenewswire.com/media/b5b65eab-3831-4f38-a1e8-b9f8d9f028d7/small/logo-1-jpg.JPG https://www.scitechpresssouthdakota.com/article/906932128-aikido-security-launches-endpoint-protection-for-developer-devices-as-software-supply-chain-attacks-hit-unprecedented-scale Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Aikido Security Launches Endpoint Protection for Developer Devices as Software Supply Chain Attacks Hit Unprecedented Scale https://ml.globenewswire.com/media/d904c396-43e8-450b-b631-3725bd6b6431/small/aikido-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932245-monte-rosa-therapeutics-presents-preclinical-data-at-american-association-for-cancer-research-aacr-annual-meeting-2026-on-the-potential-of-its Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932296-sparc-ai-signs-second-ukrainian-drone-manufacturer-expanding-distribution-footprint-for-gps-denied-software-platform Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform https://ml.globenewswire.com/media/63c144a0-5c1d-45ef-99bc-e677d522fbb0/small/sparc-ai-logo-png.png https://www.scitechpresssouthdakota.com/article/906932307-nrx-pharmaceuticals-nasdaq-nrxp-welcomes-presidential-initiative-to-accelerate-approval-of-psychedelic-medications-to-treat-depression-ptsd-and Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.scitechpresssouthdakota.com/article/906932319-seres-therapeutics-showcases-ser-155-data-and-live-biotherapeutic-insights-at-escmid-global-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.scitechpresssouthdakota.com/article/906932434-transalta-appoints-mike-politeski-as-chief-financial-officer-and-grant-arnold-as-chief-commercial-officer Sci-Tech Press South Dakota en PressRelease 2026-04-20T11:00:00+00:00 TransAlta Appoints Mike Politeski as Chief Financial Officer and Grant Arnold as Chief Commercial Officer https://ml.globenewswire.com/media/10bf7a28-0d23-4e33-a9bc-301280c82a15/small/picture2-jpg.jpg https://www.scitechpresssouthdakota.com/article/906932449-bodor-laser-ranked-no-1-in-global-sales-volume-for-seven-consecutive-years-demonstrating-brand-strength-through-sustained-leadership Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:59:15+00:00 Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership https://ml.globenewswire.com/media/914d0715-229f-408c-bd1b-fc6347965594/medium/global-no-1.jpeg https://www.scitechpresssouthdakota.com/article/906927423-ani-pharmaceuticals-announces-the-fda-approval-and-launch-of-pimozide-tablets-with-180-day-cgt-exclusivity Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:50:00+00:00 ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.scitechpresssouthdakota.com/article/906927583-evidence-supporting-combined-use-of-deucrictibant-ir-with-deucrictibant-xr-presented-at-ciic-spring-2026-conference Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:50:00+00:00 Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.scitechpresssouthdakota.com/article/906927640-silo-pharma-positioned-to-advance-treatment-targeting-ptsd-as-president-trump-signs-executive-order-aimed-at-accelerating-research-and-treatment-based Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:34:00+00:00 Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906927568-boss-zhipin-s-sustained-share-repurchases-achieved-over-rmb913-million-in-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:30:00+00:00 BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026 https://ml.globenewswire.com/media/3983f407-fe67-4bb8-b418-feb895fdada1/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906927646-prelude-therapeutics-announces-pricing-of-90-0-million-underwritten-offering Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:30:00+00:00 Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.scitechpresssouthdakota.com/article/906927595-coatingsolution4u-wins-bronze-at-the-2026-edison-awards-in-materials-science Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:18:46+00:00 CoatingSolution4U Wins Bronze at the 2026 Edison Awards in Materials Science https://ml.globenewswire.com/media/dafb33b6-6bfd-49b9-b876-e45af5f7a873/medium/coatingsolution4u-receives-bronze-edison-award-2026.jpg https://www.scitechpresssouthdakota.com/article/906922856-biodesix-to-report-first-quarter-2026-financial-results-on-may-4-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:00:00+00:00 Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.scitechpresssouthdakota.com/article/906922873-prelude-therapeutics-presents-preclinical-data-from-development-candidate-prt13722-a-first-in-class-orally-bioavailable-potent-and-highly Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:00:00+00:00 Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026 https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.scitechpresssouthdakota.com/article/906922975-greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-aacr-meeting-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:00:00+00:00 Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://www.scitechpresssouthdakota.com/article/906922984-owlting-group-nasdaq-owls-announces-12-month-lock-up-extension-supported-by-sbi-and-legacy-shareholders-representing-more-than-99-of-subject Sci-Tech Press South Dakota en PressRelease 2026-04-20T10:00:00+00:00 OwlTing Group (NASDAQ: OWLS) Announces 12-Month Lock-Up Extension Supported by SBI and Legacy Shareholders Representing More Than 99% of Subject Shares https://ml.globenewswire.com/media/f044d335-9e0f-4fe4-8ffd-3414828e326f/small/owlting-logo-primary-png.png https://www.scitechpresssouthdakota.com/article/906914097-blackrock-canada-announces-april-cash-distributions-for-the-ishares-etfs Sci-Tech Press South Dakota en PressRelease 2026-04-20T09:00:00+00:00 BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs https://ml.globenewswire.com/media/d8e03598-4c47-4766-99ee-349982dc8a59/small/ishares-png.png https://www.scitechpresssouthdakota.com/article/906909326-oculis-announces-completion-of-last-patient-visit-in-phase-3-diamond-program-with-ocs-01-eye-drops-for-the-treatment-of-diabetic-macular-edema Sci-Tech Press South Dakota en PressRelease 2026-04-20T08:00:00+00:00 Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.scitechpresssouthdakota.com/article/906909333-ngen-announces-62-7m-in-world-leading-advanced-manufacturing-projects Sci-Tech Press South Dakota en PressRelease 2026-04-20T08:00:00+00:00 NGen Announces $62.7M in World-Leading Advanced Manufacturing Projects https://ml.globenewswire.com/media/3a041e38-c23c-4a28-91f7-95b5a0bbc35a/small/ngen-colour-png.png https://www.scitechpresssouthdakota.com/article/906909337-ngen-annonce-62-7-m-en-projets-de-fabrication-de-pointe-de-calibre-mondial Sci-Tech Press South Dakota en PressRelease 2026-04-20T08:00:00+00:00 NGen annonce 62,7 M$ en projets de fabrication de pointe de calibre mondial https://ml.globenewswire.com/media/1bf2940c-316a-479e-86fa-c2876b96617f/small/ngen-icon-512-png.png https://www.scitechpresssouthdakota.com/article/906900704-makko-launches-ai-powered-2d-game-studio-with-over-40-000-game-assets-created-in-beta Sci-Tech Press South Dakota en PressRelease 2026-04-20T07:01:00+00:00 Makko launches AI-powered 2D game studio with over 40,000 game assets created in Beta https://ml.globenewswire.com/media/332747ea-9918-4714-bd49-a0ff76067a39/small/makko-logo-transparent-background-png.png https://www.scitechpresssouthdakota.com/article/906895910-nxera-pharma-to-receive-us-10-million-milestone-payment-from-abbvie-under-collaboration-targeting-neurological-diseases Sci-Tech Press South Dakota en PressRelease 2026-04-20T06:30:00+00:00 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.scitechpresssouthdakota.com/article/906895935-nanobiotix-annonce-de-nouvelles-donn-es-pr-cliniques-d-montrant-une-am-lioration-de-la-biodisponibilit-syst-mique-et-la-r-duction-de-la-toxicit-pour Sci-Tech Press South Dakota en PressRelease 2026-04-20T06:30:00+00:00 Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN delivrées par LNP après traitement avec sa technologie de… https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906896055-nanobiotix-announces-new-preclinical-data-supporting-improved-systemic-bioavailability-and-reduced-toxicity-for-lnp-delivered-dna-immunotherapy-after Sci-Tech Press South Dakota en PressRelease 2026-04-20T06:30:00+00:00 Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.scitechpresssouthdakota.com/article/906895941-tencent-invests-in-kaspi-kz-alongside-co-founder-ceo-mikheil-lomtadze-and-long-term-u-s-institutional-investors Sci-Tech Press South Dakota en PressRelease 2026-04-20T06:10:00+00:00 Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional Investors https://ml.globenewswire.com/media/1eb80226-7ba7-4120-833c-7754cb49b08c/small/logo-kaspi-png.png https://www.scitechpresssouthdakota.com/article/906891444-schneider-electric-and-deloitte-collaborate-to-drive-ai-enabled-digital-transformation-across-industrial-operations Sci-Tech Press South Dakota en PressRelease 2026-04-20T06:00:00+00:00 Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations https://ml.globenewswire.com/media/5d185555-b771-4931-ba37-33a6fc1f5d24/medium/schneider-electric-and-deloitte-collaborate-to-drive-ai-enab.jpg https://www.scitechpresssouthdakota.com/article/906891437-reminder-last-exercise-day-for-nicox-june-2024-warrants-is-june-19-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T05:30:00+00:00 Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/logo-png.png https://www.scitechpresssouthdakota.com/article/906891441-rappel-le-dernier-jour-d-exercice-pour-les-bons-de-souscription-d-actions-bsa-nicox-de-juin-2024-est-le-19-juin-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-20T05:30:00+00:00 Rappel : le dernier jour d’exercice pour les Bons de Souscription d’Actions (BSA) Nicox de juin 2024 est le 19 juin 2026 https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/ https://www.scitechpresssouthdakota.com/article/906859789-ccus-hub-study-identifies-five-asia-pacific-hub-sites-and-welcomes-new-consortium-partners Sci-Tech Press South Dakota en PressRelease 2026-04-20T02:00:00+00:00 CCUS Hub Study identifies five Asia-Pacific hub sites and welcomes new consortium partners https://ml.globenewswire.com/media/0a058e94-3af0-423e-a91c-f8eebc46597d/medium/ccus-consortium-members.jpg https://www.scitechpresssouthdakota.com/article/906845683-ascentage-pharma-to-present-four-promising-preclinical-studies-demonstrating-the-potential-of-combination-therapies-at-american-association-for-cancer Sci-Tech Press South Dakota en PressRelease 2026-04-20T00:00:00+00:00 Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.scitechpresssouthdakota.com/article/906845652-sutro-biopharma-presents-promising-preclinical-data-across-its-pipeline-of-next-generation-single-and-dual-payload-adc-programs-at-aacr-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-19T23:45:00+00:00 Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 https://ml.globenewswire.com/media/b29d64ff-a5d8-41ff-9d46-e0e332cc7f28/small/image001-png.png https://www.scitechpresssouthdakota.com/article/906841121-monopar-presents-phase-3-data-showing-greater-neurologic-benefit-with-alxn1840-vs-soc-in-wilson-disease-patients-with-neurologic-symptoms-at-aan-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-19T23:00:00+00:00 Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026 https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://www.scitechpresssouthdakota.com/article/906832668-kimmtrak-doubles-the-likelihood-of-being-alive-at-five-years-for-first-line-hla-a-02-01-patients-with-metastatic-uveal-melanoma Sci-Tech Press South Dakota en PressRelease 2026-04-19T22:00:00+00:00 KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://www.scitechpresssouthdakota.com/article/906832675-xenon-presents-azetukalner-phase-3-x-tole2-study-results-and-48-month-long-term-data-in-focal-onset-seizures-at-2026-aan-annual-meeting Sci-Tech Press South Dakota en PressRelease 2026-04-19T22:00:00+00:00 Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.scitechpresssouthdakota.com/article/906816139-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Sci-Tech Press South Dakota en PressRelease 2026-04-19T20:05:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.scitechpresssouthdakota.com/article/906816100-zealand-pharma-launches-long-term-incentive-programs-for-zealand-pharma-s-board-of-directors-corporate-management-and-employees-for-2026 Sci-Tech Press South Dakota en PressRelease 2026-04-19T20:00:00+00:00 Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.scitechpresssouthdakota.com/article/906800541-revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer Sci-Tech Press South Dakota en PressRelease 2026-04-19T18:00:00+00:00 Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.scitechpresssouthdakota.com/article/906732361-cregis-shines-at-paris-blockchain-week-2026-accelerating-european-expansion Sci-Tech Press South Dakota en PressRelease 2026-04-19T09:45:18+00:00 Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion https://ml.globenewswire.com/media/5bebd304-3269-4385-9874-50701ff2353a/medium/cover-image.jpeg https://www.scitechpresssouthdakota.com/article/906711088-challenge-accepted-schneider-electric-helps-industry-turn-toughest-problems-into-competitive-advantage Sci-Tech Press South Dakota en PressRelease 2026-04-19T07:00:00+00:00 Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage https://ml.globenewswire.com/media/f9f1757e-4ed3-4fe7-939b-35cd2b1f43e1/medium/schneider-electric.jpg https://www.scitechpresssouthdakota.com/article/906674833-direct-meds-glp-1-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying Sci-Tech Press South Dakota en PressRelease 2026-04-19T03:39:34+00:00 Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying https://ml.globenewswire.com/media/065e49c6-04a6-4223-a1ee-caea644c6a7f/medium/direct-meds.PNG https://www.scitechpresssouthdakota.com/article/906674828-strovemont-capital-claims-evaluated-is-strovemont-capital-trading-platform-legit-hidden-features-trust-facts-real-user-results Sci-Tech Press South Dakota en PressRelease 2026-04-19T03:10:24+00:00 Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results https://ml.globenewswire.com/media/6c80b7b0-a3e5-46d9-a0a2-28f7c0c723bc/medium/strovemont-capital.png https://www.scitechpresssouthdakota.com/article/906659883-bramridge-trust-unveiled-should-you-join-bramridge-trust-features-performance-fees-real-user-insights Sci-Tech Press South Dakota en PressRelease 2026-04-19T02:30:20+00:00 Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights! https://ml.globenewswire.com/media/298d2649-26e8-49ac-ab07-531c079947cf/medium/bramridge-trust.PNG https://www.scitechpresssouthdakota.com/article/906622428-crypto-news-alphapepe-ai-dex-demo-over-1000-users-whilst-xrp-price-prediction-targets-5-00-following-official-sec-commodity-status Sci-Tech Press South Dakota en PressRelease 2026-04-18T22:45:00+00:00 Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status https://ml.globenewswire.com/media/bb8173de-d338-4af5-9802-2bcdb498429b/medium/alphapepe.jpg